As artificial intelligence and programmable biology rapidly converge, a new generation of companies, tools, and research paradigms is emerging across the life sciences. From AI-driven protein design and generative genomics to autonomous laboratories and foundation models for biology, the AIxBIO ecosystem is evolving at unprecedented speed. In this session, NVIDIA will present a high-level overview of the AIxBIO landscape, highlighting key technological breakthroughs, emerging categories of companies, and the infrastructure powering the next wave of biological discovery. The discussion will explore how advances in compute, data, and machine learning are reshaping how we design molecules, engineer cells, and accelerate drug and materials discovery. This talk will provide a strategic map of the field and help frame where the most important opportunities and bottlenecks lie as AI begins to fundamentally transform the practice of biology.